BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
26 results:

  • 1. Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells.
    Liu M; Dong Q; Chen B; Liu K; Zhao Z; Wang Y; Zhuang S; Han H; Shi X; Jin Z; Hui Y; Gu Y
    Br J Cancer; 2023 Oct; 129(8):1339-1349. PubMed ID: 37620409
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma.
    Poizeau F; Balusson F; Lemaitre F; Tron C; Pracht M; Russo D; Dinulescu M; Lesimple T; Oger E; Dupuy A
    Br J Dermatol; 2023 Mar; 188(4):482-490. PubMed ID: 36760148
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
    Barak V; Kalickman I; Pe'er J
    Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Blue light induces ROS mediated apoptosis and degradation of aml1-ETO oncoprotein in Kasumi-1 cells.
    Zhuang J; Xia L; Zou Z; Yin J
    Med Oncol; 2022 Feb; 39(5):52. PubMed ID: 35150326
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Research progress on primary orbital melanoma].
    Wang JJ; Ma JM
    Zhonghua Yan Ke Za Zhi; 2021 Nov; 57(11):861-864. PubMed ID: 34743473
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis.
    Li J; Wang J; Li D; Wen X; Ding Y; Liu X; Jiang H; Huang F; Zhang X
    Dermatol Ther; 2021 Sep; 34(5):e15067. PubMed ID: 34302318
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. treatment of Cutaneous Squamous Cell Carcinoma In Situ With Curettage Followed by Topical Imiquimod 5% Cream.
    Ondo AL; Kerner JD; Kerner JV; Ondo IP; Trainor P; Shanler SD
    Dermatol Surg; 2021 May; 47(5):609-612. PubMed ID: 33905391
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Surgical excision margins in primary cutaneous melanoma: A systematic review and meta-analysis.
    Hanna S; Lo SN; Saw RP
    Eur J Surg Oncol; 2021 Jul; 47(7):1558-1574. PubMed ID: 33722422
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in Northern Portugal.
    Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N
    Int J Cancer; 2021 Jul; 149(2):287-296. PubMed ID: 33634852
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study.
    Long GV; Dummer R; Hamid O; Gajewski TF; Caglevic C; Dalle S; Arance A; Carlino MS; Grob JJ; Kim TM; Demidov L; Robert C; Larkin J; Anderson JR; Maleski J; Jones M; Diede SJ; Mitchell TC
    Lancet Oncol; 2019 Aug; 20(8):1083-1097. PubMed ID: 31221619
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. cancer treatment and survivorship statistics, 2019.
    Miller KD; Nogueira L; Mariotto AB; Rowland JH; Yabroff KR; Alfano CM; Jemal A; Kramer JL; Siegel RL
    CA Cancer J Clin; 2019 Sep; 69(5):363-385. PubMed ID: 31184787
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Gingival squamous cell carcinoma diagnosed on the occasion of osteonecrosis of the jaw in a patient with chronic GVHD].
    Tsukada S; Itonaga H; Taguchi J; Miyoshi T; Hayashida S; Sato S; Ando K; Sawayama Y; Imaizumi Y; Hata T; Umeda M; Niino D; Miyazaki Y
    Rinsho Ketsueki; 2019; 60(1):22-27. PubMed ID: 30726819
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
    Meserve J; Aniwan S; Koliani-Pace JL; Shashi P; Weiss A; Faleck D; Winters A; Chablaney S; Kochhar G; Boland BS; Singh S; Hirten R; Shmidt E; Hartke JG; Chilukuri P; Bohm M; Sagi SV; Fischer M; Lukin D; Hudesman D; Chang S; Gao Y; Sultan K; Swaminath A; Gupta N; Kane S; Loftus EV; Shen B; Sands BE; Colombel JF; Siegel CA; Sandborn WJ; Dulai PS
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1533-1540.e2. PubMed ID: 30268561
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Systematic Review of Surgical treatment and Outcomes After Local Surgery of Primary Cutaneous Melanomas of the Penis and Scrotum.
    Bittar JM; Bittar PG; Wan MT; Kovell RC; Guzzo TJ; Shin TM; Etzkorn JR; Sobanko JF; Miller CJ
    Dermatol Surg; 2018 Sep; 44(9):1159-1169. PubMed ID: 29985865
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Effect of Phototherapy on cancer Predisposition Genes of Diabetic and Normal Human skin Fibroblasts.
    Chotikasemsri P; Tangtrakulwanich B; Sangkhathat S
    Biomed Res Int; 2017; 2017():7604861. PubMed ID: 28386563
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Revisions in Implant-Based Breast Reconstruction: How Does Direct-to-Implant Measure Up?
    Clarke-Pearson EM; Lin AM; Hertl C; Austen WG; Colwell AS
    Plast Reconstr Surg; 2016 Jun; 137(6):1690-1699. PubMed ID: 27219225
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry.
    van de Wal M; van de Poll-Franse L; Prins J; Gielissen M
    Psychooncology; 2016 Jul; 25(7):772-8. PubMed ID: 26464337
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.
    Schadendorf D; Hodi FS; Robert C; Weber JS; Margolin K; Hamid O; Patt D; Chen TT; Berman DM; Wolchok JD
    J Clin Oncol; 2015 Jun; 33(17):1889-94. PubMed ID: 25667295
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.